Undark
From this contributor
Evidence linking acetaminophen to autism, ADHD under debate again
As acetaminophen lawsuits make their way through the U.S. court system, researchers reevaluate the quality of the evidence linking in-utero exposure to the painkiller to neurodevelopmental issues in children.
Evidence linking acetaminophen to autism, ADHD under debate again
Psychology research skews mostly white and wealthy
For decades, the overwhelming majority of psychology research has examined people who live in the United States and other affluent Western countries — presenting a skewed view of the human mind.
Psychology research skews mostly white and wealthy
The cost of a delayed autism diagnosis
Many people go more than half of their lives before learning that they are autistic; one writer on the spectrum believes we can do better.
The cost of a delayed autism diagnosis
Canada makes clinical trial data available to public
Canada's health department is now sharing study results on new drugs and treatments online. Transparency advocates want the United States to do the same.
Canada makes clinical trial data available to public
What it’s like to be autistic at an autism research conference
An autistic journalist is cautiously optimistic that the annual INSAR conference is becoming more inclusive of the autism community.
What it’s like to be autistic at an autism research conference
Explore more from The Transmitter
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
Michael Shadlen explains how theory of mind ushers nonconscious thoughts into consciousness
All of our thoughts, mostly nonconscious, are interrogations of the world, Shadlen says. The opportunity to report our answers to ourselves or others brings a thought into conscious awareness.
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
‘Peer review is our strength’: Q&A with Walter Koroshetz, former NINDS director
In his first week off the job, the former National Institute of Neurological Disorders and Stroke director urges U.S. scientists to remain optimistic about the future of neuroscience research, even if the executive branch “may not value what we do.”
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.
Viral remnant in chimpanzees silences brain gene humans still use
The retroviral insert appears to inadvertently switch off a gene involved in brain development.